How semaglutide can affect your period — and what to do about it

Weight-related hormone shifts are the most common reason semaglutide changes period patterns — not a direct drug effect on the uterus.
Cycles can become irregular, lighter, heavier, or temporarily absent, particularly in the first few months of treatment.
Increased fertility is a real possibility as weight falls, effective contraception matters from day one of treatment.
For tirzepatide specifically, oral contraceptive absorption may be reduced at the start of treatment and after each dose increase; semaglutide carries a different evidence base on this point.

Semaglutide can influence your menstrual cycle, and it does so through more than one route. Rapid weight loss reshapes hormone levels, which in turn affects how regularly (and how heavily) periods arrive. That said, the picture is rarely straightforward, and every person's experience differs. These are prescription-only medicines, and a prescriber will assess whether treatment is right for you before anything is dispensed.

Starting from £29.99/mo

Free 2-minute consultation · Reviewed same day

Start journey
The nume Promise

Order by 12pm.

At your door the next working day.
Free, tracked, plain packaging.

Guaranteed on approved orders

Where are you starting from?

BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.

Check your BMI.

Ten seconds. Private — nothing is stored or shared.

80 kg
170 cm

Your result updates live in the card alongside.

Your result

Your BMI is

which is in the healthy weight range

Start journey

BMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.

Treatment options

Weight loss treatments

The problem

Most weight loss services treat you like a transaction, a checkout, a courier, and you're on your own.

Algorithm approvalsNo real clinicianGeneric dosingHidden feesSlow deliverySilence after checkout

The nume way

We built the opposite: one clinician who knows you, guaranteed care at every step.

24 hrs

clinician review. Free next working day delivery.

How it works

From consultation to your door, properly.

Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.

Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.

Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.

Understanding what semaglutide is doing to your cycle, and the decisions that follow

Why semaglutide changes periods: the hormone chain to understand

When body weight falls at pace, fat tissue (which produces oestrogen) decreases. That reduces the amount of oestrogen circulating in the body, which can disrupt the hormonal signalling that governs ovulation and the menstrual cycle. It is not that semaglutide is targeting the uterus; the medicine is changing the metabolic environment, and the cycle responds to that change.

There is also a second thread worth knowing. Polycystic ovary syndrome (PCOS) affects a significant proportion of people with obesity, often suppressing or irregularising periods. As insulin sensitivity improves and weight falls on semaglutide, some people find their cycles become more regular rather than less, sometimes for the first time in years. So the same medicine can push in opposite directions depending on where someone starts.

Stress, sleep, and calorie restriction (which often accompanies treatment) can add further variability. The overall effect semaglutide has on periods is, in short, highly individual. If you have been living with irregular cycles and are now noticing changes, that context matters when you speak to a prescriber. You are not imagining it, and there is usually a reason.

The specific changes most commonly reported, and when to take them seriously

The most frequently described changes are cycles arriving earlier or later than expected, periods becoming lighter, and occasional missed periods in the first three to six months of significant weight loss. Some people also notice the reverse: heavier or more prolonged periods when hormonal patterns shift. Neither direction is inherently alarming on its own, but both are worth noting.

A missed period when you are taking semaglutide and are sexually active should prompt a pregnancy test. This is not a precautionary reflex, it reflects a genuine mechanism. As weight falls, fertility can return or increase, sometimes before any cycle change makes that obvious. The question of periods stopping on Wegovy is one of the most common things prescribers field, and the honest answer is that the cause needs ruling in before it can be managed.

Seek medical advice promptly if you experience very heavy bleeding (soaking through more than one pad per hour for several hours), severe pelvic pain, or any bleeding after a confirmed pregnancy. These are not expected effects of semaglutide and need assessment in their own right, independent of your weight-loss treatment.

Contraception: the practical decision this raises

Increased fertility during weight loss is well-established, and NHS guidance is clear: use effective contraception while on GLP-1 medicines and for a wash-out period before trying to conceive. If you are on oral contraceptives and are starting or increasing a dose of semaglutide, the evidence base suggests no significant reduction in pill absorption, unlike tirzepatide, where NHS guidance specifically recommends adding a non-oral method for the first four weeks of treatment and for four weeks after each dose increase.

That distinction matters. If you are considering switching between treatments or are already on one and unsure whether your contraceptive is still reliably absorbed, this is exactly the kind of question worth raising with a prescriber rather than resolving by assumption. The relationship between Wegovy and your cycle has practical implications that go beyond period tracking, and a brief clinical conversation can clear them up. There is a broader overview of what Wegovy is and how it works if you are still building up that picture.

Semaglutide is not recommended during pregnancy or breastfeeding, or when actively trying to conceive. If you are planning a pregnancy, discuss timing with your prescriber well in advance. The NHS England guidance on weight-management injections addresses contraception and reproductive health in detail and is worth reading alongside your prescriber's advice. NHS England's guidance on weight-management injections sets this out clearly.

When to bring this up with a prescriber, and how nume fits in

If your cycle has changed noticeably since starting semaglutide, you do not need to wait for a scheduled review to raise it. Changes to period pattern, unexpected weight on the heaviest end of the spectrum, missed periods with a negative test, or anything that worries you are all reasonable reasons to get in touch with whoever oversees your treatment. At nume, aftercare is available seven days a week, there is no queue to join for a concern that does not fall neatly on a weekday.

If you are thinking about starting semaglutide and want to understand how it might interact with your cycle before you commit, that is a sensible question to bring to a consultation. Prescribers at our clinical team review each consultation personally, not by algorithm, and reproductive health factors form part of a thorough clinical picture. If you would like a sense of what private treatment costs before you take that step, the Wegovy price comparison page covers what UK pricing typically includes.

The right moment to discuss any of this is sooner rather than later. Check your eligibility and speak to our prescribers whenever you are ready.

Looking to start your weight loss journey?
Take a quick eligibility quiz to explore your options and see how we can support you.
Start free consultation

The people

Meet the team.

Mahommed Zunaid Ayub Patel

Superintendent Pharmacist (GPhC No. 2217101)

Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.

Mostafa Damghani

Clinical Lead (GPhC No. 2231744)

Sets our clinical standards and checks everything we publish against current MHRA guidance.

Shelan Salih

Independent Prescriber (GPhC No. 2084501)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Rehenaaz Uddin

Independent Prescriber (GPhC No. 2083426)

Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.

Frequently asked questions